PMID: 2485284Jan 1, 1988Paper

Maintaining smoking abstinence after myocardial infarction

Journal of Substance Abuse
K A Perkins

Abstract

Maintaining smoking abstinence after a myocardial infarction (MI) greatly reduces risks of recurrent disease morbidity and of mortality. Although post-MI patients appear to have better long-term rates of smoking abstinence compared with healthy groups, studies employing biochemical verification of smoking status generally indicate that only about one third of previously smoking post-MI patients remain abstinent at follow-up. Factors which may accompany the occurrence of a MI and which may be associated with maintenance of smoking abstinence include environmental changes aiding cessation (e.g., decreased exposure to smoking cues), increased social support from family, and stronger belief in the harmful effects of continued smoking. The usefulness of these factors in developing new treatments for maintaining abstinence in post-MI patients is discussed, and commonalities between efforts to maintain smoking abstinence in post-MI patients and avoidance of substance abuse in other groups at risk for serious health consequences are briefly noted.

References

Feb 22, 1975·Lancet·C WilhelmssonL Wilhelmsen
Jan 1, 1978·Addictive Behaviors·O PomerleauM Pertschuk
Oct 28, 1978·British Medical Journal·R W SillettK P Ball
Sep 29, 1976·Psychopharmacology·P OhlinH Westling
Jun 1, 1977·American Journal of Public Health·D W WestG Wilkinson
Jun 1, 1977·British Journal of Preventive & Social Medicine·M Mallaghan, J Pemberton
Oct 1, 1977·American Journal of Public Health·S H Croog, N P Richards
Jul 1, 1986·The American Psychologist·K D BrownellG T Wilson
Oct 1, 1987·American Journal of Public Health·G C Kabat, E L Wynder
Jun 1, 1987·The International Journal of the Addictions·K A PerkinsP M Dubbert
Apr 1, 1986·Journal of Behavioral Medicine·R C Katz, N N Singh
Jun 19, 1986·The New England Journal of Medicine·J GoldenW Steinmann
Nov 1, 1986·The International Journal of the Addictions·K A Perkins, R R Scott
Mar 1, 1987·American Journal of Public Health·J K OckeneT J Raia
Jan 1, 1985·Addictive Behaviors·R R Scott, D Lamparski
Aug 22, 1985·The New England Journal of Medicine·J E Fielding
Aug 29, 1985·The New England Journal of Medicine·J E Fielding
Jun 1, 1985·The International Journal of the Addictions·C D TunstallS M Hall
Apr 27, 1985·British Medical Journal·M Raw
Jan 30, 1986·The New England Journal of Medicine·A P HallstromR Ray
May 24, 1985·JAMA : the Journal of the American Medical Association·C H Hennekens, J E Buring
Jun 1, 1985·American Journal of Public Health·L T MidanikK Soghikian
Apr 1, 1985·Postgraduate Medical Journal·J Perkins, T B Dick
Mar 1, 1985·Preventive Medicine·K M CummingsG Giovino
Nov 1, 1985·The American Journal of Medicine·A Strieber
Jan 1, 1985·Journal of Chronic Diseases·J K OckeneJ E Dalen
Sep 1, 1985·Preventive Medicine·J F Morris, W Temple
Feb 23, 1974·Lancet·A BurtR Turner
Oct 1, 1971·Journal of Clinical Psychology·W A HuntL G Branch
Dec 1, 1971·Journal of Health and Social Behavior·R A Eisinger
Dec 1, 1984·British Journal of Addiction·M Jarvis
Apr 12, 1984·The New England Journal of Medicine·J DeanfieldK Fox
May 19, 1984·British Medical Journal·K JamrozikH Van Vunakis
Mar 1, 1984·Journal of Behavioral Medicine·S R Sutton, J R Eiser
May 1, 1983·British Heart Journal·N HickeyC Kennedy
Dec 1, 1981·British Journal of Addiction·G RonanR Mulcahy

❮ Previous
Next ❯

Citations

Jul 11, 1991·Journal of General Internal Medicine·N A RigottiG E Thibault
Feb 1, 1984·The American Journal of Cardiology·R M NorrisB G Barratt-Boyes
Jan 1, 1984·Journal of Psychosomatic Research·I WiklundC Wilhelmsson
May 1, 1983·Progress in Cardiovascular Diseases·G J Goldman, A D Pichard
Jan 1, 1985·Addictive Behaviors·R R Scott, D Lamparski
Oct 1, 1988·Journal of the American College of Cardiology·T E KottkeP Maxwell
Oct 1, 1993·Journal of the American College of Cardiology·T E Kottke
Nov 15, 1993·Journal of the American College of Cardiology·C T Orleans, J K Ockene
Apr 3, 1999·International Journal of Cardiology·T NishiueT Iwasaka
Sep 15, 2000·Journal of the American College of Cardiology·R T van DomburgA J Bogers
Jun 1, 1985·Journal of the American College of Cardiology·M F Oliver
Jan 10, 1998·Patient Education and Counseling·K McKenna, H Higgins
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·J M SchmitzJ Grabowski
Mar 1, 1995·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·R M KaplanJ P Pierce
Mar 31, 2007·Preventive Cardiology·Beth C BockRaymond Niaura
Feb 1, 1996·Cardiology Clinics·N A Rigotti, R C Pasternak
Jan 20, 2010·Journal of the American College of Cardiology·Yariv GerberUNKNOWN Israel Study Group on First Acute Myocardial Infarction
Sep 20, 2006·Emergency Medicine Clinics of North America·Gail D'OnofrioRobert H Woolard
May 12, 2001·Italian Heart Journal : Official Journal of the Italian Federation of Cardiology·C DiClemente
Apr 30, 1999·Proceedings of the Association of American Physicians·M C FioreM E Burns
Mar 15, 2008·Critical Pathways in Cardiology·Beth C Bock, Bruce Becker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.